课题基金 / 基金详情

FUNCTIONAL DISSECTIONS OF VEGF RECEPTORS IN ENDOTHELIUM

FUNCTIONAL DISSECTIONS OF VEGF RECEPTORS IN ENDOTHELIUM
内皮细胞 VEGF 受体的功能性解剖
批准号:
6135361
负责人:
HUIYAN ZENG
金额:
$3.24万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
未结题
起止时间:
2000-03-15 至

项目摘要

项目成果

HUIYAN ZENG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Angiogenesis plays a pivotal role in many important disease processes as well as in normal physiology. It is widely anticipated that modulation of angiogenesis (inhibition in tumors, stimulation in vascular insufficiency) will provide important therapeutic benefit. Many different cytokines and growth factors express angiogenic activity, of these VPF/VEGF stands out because of its potency, selectivity for vascular endothelium, and its consistent overexpression in malignant tumors and in other clinical conditions in which angiogenesis plays an important role. VPF/VEGF acts selectively (though not exclusively) on endothelial cells (EC) by means of two high affinity receptor tyrosine kinases Flt-1 and KDR/Flk-1. Both of these receptors are expressed at increased levels by EC during development and in pathophysiological angiogenesis. Since, most of the endothelial cells express both of the receptors and both of them can homodimerize upon binding to VPF/VEGF, therefore it is difficult to comprehend the molecular function of the individual receptor in the presence of the same ligand. The proposed study aims to dissect the functional aspects and sole responsiveness of these receptors for VPF/VEGF mediated signaling in EC. Chimeric receptors of both KDR and Flt-1 and their respective mutants will be utilized to study signaling pathways responsible for KDR and Flt-1 in vascular endothelial cells. The proposed study thus will delineate the individual role of these two receptors in VPF/VEGF-mediated signaling and will also shed new light on the molecular mechanisms of angiogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Down Syndrome Candidate Region 1 isoform 1L in tumor growth and metastasis
Down Syndrome Candidate Region 1 isoform 1L in tumor growth and metastasis
Targeting orphan nuclear receptor TR3/Nur77 for tumor angiogenesis
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm
海外基金